Neurotransmission GABA

Acamprosate. Acamprosate (calcium acetylhomotaurinate), an amino acid derivative, affects both GABA and excitatory amino acid (i.e., glutamate) neurotransmission (the latter effect most likely being the one that is important for its therapeutic effects in alcoholism). Initially evaluated in a singlecenter trial in France, acamprosate was shown to be twice as effective as placebo in reducing the rate at which alcoholic patients returned to drinking (Lhuin-tre et al. 1985). The safety and efficacy of the medication have been studied most widely in Europe, and three of these studies provided the basis for the recent approval of acamprosate by the FDA for clinical use in the United States. As with naltrexone, there exist a number of meta-analytic studies that provide consistent evidence of the efficacy of the medication in the treatment of alcohol dependence. 

Of course, while the identification of these distinct systems may be useful there are many neural pathways that would not fit easily into one of them. Thus some inhibitory pathways, such as that from the caudate nucleus to substantia nigra, utilising GABA, are not intrinsic neurons. The dopamine pathway from the substantia nigra to striatum may start from a small nucleus but unlike other monoamine pathways it shows little ramification beyond its influence on the striatum. The object of the above classification is not to fit all neural pathways and mechanisms into a restricted number of functional categories but again to demonstrate that there are different forms of neurotransmission. 

Lewis, D. A., Volk, D. W. and Hashimoto, T. Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia a novel target for the treatment of working memory dysfunction. Psychopharmacology 174 143-150,... 

Ultrasonic vocalizations are emitted by rat pups (under the age of 14 days) when they are isolated from their mother, and are thought to reflect anxiety. This measure has proven sensitive to both anxiolytic and anxiogenic manipulation of GABA neurotransmission. However, the early developmental window used is problematic, in that chronic drug administration probably results in a variety of compensatory changes not seen in adulthood, and may alter development of relevant brain systems. Indeed, in contrast to the clinical situation, the antidepressant clomipramine has acute, but not chronic, anxiolytic efficacy in this model. 

Barnard, E. A. (2001) The molecular architecture of GABAa receptors, in Pharmacology of GABA and Glycine Neurotransmission, vol. 150 (Mohler, H ed.), Springer-Verlag, Berlin, pp. 79-100. 

So, methyixanthines cause a disinhibited release of excitatory amino acids. Caffeine also has a net disinhibitory effect on GABA neurotransmission (Kardos and Blandl 1994). It enhances GABA release in the spinal cord through nonbenzodiazepine mechanisms (Berti and Nistri 1983). 

Amino acid neurotransmitter Constituents of hypericum also appear to have effects on amino acid neurotransmission, particularly GABA. Hypericin and a crude extract bind to GABAA and GABAB receptors (Cott 1997). Hyperforin also inhibits synaptosomal GABA reuptake in the low micromolar range (IC50 values of 0.05-0.10 ug/ml). Activity at GABAA benzodiazepine receptors was noted in extracts of four hy-... 

So far attention has concentrated on the effects of lithium on excitatory transmitters. There is evidence that the drug can also facilitate inhibitory transmission, an effect that has been attributed to a desensitization of the pres)maptic gamma-aminobutyric acid (GABA) receptors, which results in an increase in the release of this inhibitory transmitter. The increased conversion of glutamate to GABA may also contribute to this process. Thus it would appear that lithium has a varied and complex action on central neurotransmission, the net result being a diminution in the activity of excitatory transmitters and an increase in GABAergic function. 

This dual activity against both nematode and arthropod parasites of animals was an unexpected bonus from a screen for anthelmintic agents. The reason for this broad activity lies in their mode of action. They act by interfering with y-aminobutyric acid (GABA) mediated neurotransmission. When treated with avermectin, the nematode Ascaris suum becomes paralyzed although it retains normal muscle tone (17). Picrotoxin, an antagonist of GABA, can reverse the effect of avermectin on neurotransmission vitro. 

The absence of GABA-mediated neurotransmission in cestodes and trema-todes explains the lack of activity of the avermectins against these organisms. 

Pharmacology Benzodiazepines appear to potentiate the effects of gamma-aminobutyrate (GABA) (ie, they facilitate inhibitory GABA neurotransmission) and other inhibitory transmitters by binding to specific benzodiazepine receptor sites. 

---